The Chemours Company
CC
$16.87
-$1.12-6.23%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.04% | -7.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.04% | -7.43% | |||
| Cost of Revenue | -7.06% | -5.76% | |||
| Gross Profit | -32.34% | -15.47% | |||
| SG&A Expenses | 0.00% | -41.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.33% | -9.85% | |||
| Operating Income | -74.04% | 44.44% | |||
| Income Before Tax | -231.37% | 119.54% | |||
| Income Tax Expenses | 44.44% | -107.56% | |||
| Earnings from Continuing Operations | -203.33% | 115.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -201.67% | 115.75% | |||
| EBIT | -74.04% | 44.44% | |||
| EBITDA | -28.42% | 20.39% | |||
| EPS Basic | -201.58% | 115.74% | |||
| Normalized Basic EPS | -162.72% | 302.91% | |||
| EPS Diluted | -202.86% | 115.71% | |||
| Normalized Diluted EPS | -162.90% | 301.74% | |||
| Average Basic Shares Outstanding | 0.10% | 0.05% | |||
| Average Diluted Shares Outstanding | -0.21% | 0.36% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -2.13% | 7.35% | |||